Latest Blood Stories

BEDFORD, Mass., Feb. 5, 2013 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced the release of their new HemosIL AcuStar von Willebrand Factor (VWF) assay panel as a European CE IVD Mark product under the European Directive on in vitro Diagnostic Medical Devices. The CE IVD Mark allows IL to commence distribution of the product in the European Union and other international territories. The fully automated HemosIL AcuStar VWF assay panel, designed exclusively for use on...

Malaria in pregnancy causes a range of adverse effects, including abortions, stillbirths, premature delivery and low infant birth weight. Many of these effects are thought to derive from a placental inflammatory response resulting from interaction of infected red blood cells with the placental tissue. In a study published in the latest issue of the journal PLOS Pathogen, a researchers' team led by Carlos Penha-Gonçalves at the Instituto Gulbenkian de Ciência (IGC), Portugal, observed, for...

April Flowers for redOrbit.com - Your Universe Online Where do art and medical science meet? This year, apparently, they meet at the neck of an owl. A team of medical illustrators and neurological imaging experts from Johns Hopkins University School of Medicine has finally discovered how owls can almost fully rotate their heads without damaging the delicate blood vessels in their neck. Unlike most animals which are far more vulnerable to neck injuries, the nocturnal birds are able to...

MONMOUTH JUNCTION, N.J., Jan. 29, 2013 /PRNewswire/ -- CytoSorbents Corporation (OTCBB:CTSO), a critical care focused company using blood purification to treat life-threatening illnesses, announced today that, as an approved participant of the Technology Business Tax Certificate Transfer Program sponsored by the New Jersey Economic Development Authority, it has received $391,562 from the sale of its prior unused net operating loss carryovers. These funds are non-dilutive to...

GeneCell International and its subsidiary Celulas Madre, Two Internationally Renowned Providers in the Processing and Preservation of Umbilical Cord Blood Stem Cells, Announced Today the Opening of its New Clinical Laboratory, “BIOCEMA”, in Maracay, Venezuela. Miami, Florida (PRWEB) January 28, 2013 GeneCell International, with its Corporate Headquarters located in Miami, Florida, collects and stores umbilical cord blood, cord segment tissue, dental pulp and adipose (fat) tissue that...

Mississippi Valley Regional Blood Center measures hospital user satisfaction; results exceed expectations Davenport, Iowa (PRWEB) January 28, 2013 Mississippi Valley Regional Blood Center has received overwhelmingly positive feedback from its first user satisfaction survey of BloodHub, the Center’s online ordering and blood supply chain solution. MVRBC’s primary focus was on quantifying ease of use as a primary measure of user acceptance. The results were clear:...

Up to one-third of patients undergoing surgery in Ontario have a treatable form of anemia but are not optimally treated for it. A paper published online today in the Canadian Journal of Anesthesia says that hospitals that do treat patients with anemia have better outcomes, including fewer blood transfusions and infections and shorter hospital stays. A common option for management of anemia has been blood transfusion. But blood transfusions are expensive and are associated with higher...

[195 Pages Report] Apheresis Market report categorizes the global market into procedure, application (Plasmapheresis, Plateletpheresis & Erythrocytapheresis), technology, product type and end-user. (PRWEB) January 24, 2013 MarketsandMarkets recently conducted a study on the “Apheresis Market - Applications (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, Photopheresis), Procedures (Therapeutic & Donor Apheresis/Automated Blood Component Collection), Devices...

KING OF PRUSSIA, Pa., Jan. 21, 2013 /PRNewswire/ -- CSL Behring has announced that the first patient has been enrolled in the pivotal pediatric phase III study to evaluate the safety, efficacy and pharmacokinetics of recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP) in previously treated children (up to age 11 years). The study site for this first enrollment is the Czech Republic. "CSL continues to advance at a very encouraging rate with...

Johns Hopkins research suggests routine preventive measures won't stop all clots Despite receiving blood thinners and other clot prevention treatment, some patients still develop potentially lethal blood clots in the first month after their operations anyway, especially if they developed a surgical-site infection while in the hospital, according to results of a study at Johns Hopkins. The research, described in a report published in the Journal of the American College of Surgeons, found...